Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5%
Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5%
Source: directorstalkinterviews.com
Stay updated with breaking news from Ishbel Macpherson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5%
3 FTSE 250 Directorate changes, Baillie Gifford Japan, Dechra Pharmaceuticals and Great Portland Estates
Investegate announcements from Dechra Pharmaceutcls, Form 8 (OPD) - Dechra Pharmaceuticals PLC
Investegate announcements from Dechra Pharmaceutcls, Result of AGM
He still gets by on £2million a year, but the drop makes unrest unlikely when shareholders vote on executive rewards.